Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome—positive acute lymphoblastic leukemia
Year: 2007
Type: article
Source: Clinical Therapeutics
Author: Michael Steinberg
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: dasatinib, tyrosine kinase inhibitors, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, BCR-ABL, imatinib resistance, BCR-ABL mutations, START trial, pharmacokinetics, adverse effects, cytogenetic response, hematologic response, chronic phase CML, blast crisis, accelerated phase CML, imatinib, dasatinib resistance
Open Access status: closed
OpenAlex ID: W2162720854
